NCT04410133 2025-08-28
REVELATE
Blue Earth Diagnostics
Phase 3 Completed
Clinical Trials
6 trialsNCT04410367 2025-07-20
PURSUE
Blue Earth Diagnostics
Phase 2 Completed
NCT03926507 2024-10-09
F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
M.D. Anderson Cancer Center
Phase NA Completed
NCT04114370 2022-12-06
FACBC
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT03990285 2021-12-22
Axumin
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT03930173 2021-05-05
18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation Necrosis
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed